Clinical Trials Logo

Type 2 Diabetes Mellitus clinical trials

View clinical trials related to Type 2 Diabetes Mellitus.

Filter by:

NCT ID: NCT01254552 Completed - Clinical trials for Type 2 Diabetes Mellitus

Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis

ACCREDIT
Start date: August 2010
Phase: Phase 4
Study type: Interventional

The study aimed to prospectively investigate the prevalence of myocardial scar on Dotarem-enhanced Cardiovascular Magnetic Resonance Imaging (MRI) in asymptomatic patients with type-2 Diabetes Mellitus and to assess its correlation with subclinical coronary artery disease on Cardiac Computed Tomography Angiography (CCTA).

NCT ID: NCT01242228 Completed - Clinical trials for Type 2 Diabetes Mellitus

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With Dipeptidyl Peptidase-4 (DPP-4) Inhibitor in Type 2 Diabetic Patients

Start date: October 21, 2010
Phase: Phase 3
Study type: Interventional

This study is to evaluate long-term safety and efficacy after concomitant administration of ASP1941 and DPP-4 inhibitor in Japanese patients with type 2 diabetes mellitus.

NCT ID: NCT01242215 Completed - Clinical trials for Type 2 Diabetes Mellitus

A Study to Assess the Efficacy and Safety of ASP1941 in Combination With Sulfonylurea in Type 2 Diabetic Patients

Start date: September 17, 2010
Phase: Phase 3
Study type: Interventional

This study is to evaluate the efficacy and safety after concomitant administration of ASP1941 and sulfonylurea in patients with diabetes mellitus.

NCT ID: NCT01242202 Completed - Clinical trials for Type 2 Diabetes Mellitus

A Study to Assess the Safety and Efficacy of ASP1941 in Combination With α-glucosidase Inhibitor in Type 2 Diabetic Patients

Start date: October 21, 2010
Phase: Phase 3
Study type: Interventional

This study is to evaluate long-term safety and efficacy after concomitant administration of ASP1941 and α-glucosidase inhibitor in Japanese patients with type 2 diabetes mellitus.

NCT ID: NCT01241474 Completed - Clinical trials for Type 2 Diabetes Mellitus

Effect of Fish Oil on Insulin Sensitivity

Start date: February 2009
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether a prolonged (9 month) high (6g/d) of marine oil improves insulin sensitivity and glucose control in subjects with impaired glucose regulation.

NCT ID: NCT01241253 Completed - Clinical trials for Type 2 Diabetes Mellitus

Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus

Start date: November 2009
Phase: Phase 2
Study type: Interventional

The study uses a randomized, placebo-controlled experimental design consisting of 4 different test treatments matched on carbohydrate (CHO) content. The three beans are similar in their CHO content amount for ½ cup at ~20 grams CHO. Each of the bean varieties will be served in a ~½ cup serving size with ~ ½ cup of plain steamed white rice (30 grams CHO) for a total of 50 grams of CHO per meal for each of the three test treatments. The 4th placebo or control treatment consists of ~ 7/8 cup of rice alone, an amount consistent with the CHO content of the test meals. Most diabetic meal plans recommend no more than 45-60 grams of CHO per meal. Fifty grams of CHO is a standard amount for glycemic response testing in general. The investigators hypotheses were: - The test meals containing the three bean types in combination with white rice will decrease the participants' glycemic response when eaten as part of a meal. - The reduction in post-prandial glycemia will not differ between bean types in the elicited responses among individuals with type 2 diabetes.

NCT ID: NCT01240759 Completed - Clinical trials for Type 2 Diabetes Mellitus

Safety and Efficacy of S-707106 in Subjects With Type 2 Diabetes Mellitus and Inadequate Glycemic Control With Metformin Therapy

Start date: October 2010
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and efficacy of S-707106 co-administered with metformin in subjects with type 2 diabetes mellitus.

NCT ID: NCT01240252 Completed - Clinical trials for Type 2 Diabetes Mellitus

Insulin Receptor Substrate 1 (IRS-1) Regulation in Insulin Resistance

Start date: March 2012
Phase: Phase 1
Study type: Interventional

The study is being conducted to find out why too much fat in your blood stream may cause insulin resistance in your muscles. Insulin is the hormone, produced normally by your body, which causes your blood sugar to return to normal after you eat.

NCT ID: NCT01238978 Completed - Clinical trials for Type 2 Diabetes Mellitus

Phase 4 Study in the Elderly Patients With T2DM

GLYCEMIA
Start date: October 2010
Phase: Phase 4
Study type: Interventional

The study will assess the incidence of Hypoglycemia: Percent of patients presenting no hypoglycemia (confirmed events with SMBG and severe episodes) over 6 months follow up in T2DM patients treated with a DPP-4 inhibitor or another OAD as add-on therapy to metformin

NCT ID: NCT01236846 Completed - Clinical trials for Type 2 Diabetes Mellitus

Vitamin D Receptor Polymorphisms and Efficacy of Vitamin D-Fortified Yogurt Drink in Patients With Type 2 Diabetes

Start date: October 2009
Phase: N/A
Study type: Interventional

Study is a 12-week Double blind,controlled experiments designed to examine the possible effects of vitamin D receptor gene polymorphisms on the metabolic, inflammatory and oxidative stress markers in type 2 diabetic patients to vitamin D-fortified yogurt drink intake.